Gram SPN 500mg/250mg Injection
Marketer
Staunch Biotech
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Gram SPN 500mg/250mg Injection
This dual-strength injectable medication, containing 500mg/250mg of Gram SPN, combats various bacterial infections by inhibiting microbial growth and spread. Administration must be solely under a healthcare provider's guidance. Consistent adherence to the prescribed treatment schedule is crucial, even with symptom improvement; premature cessation may reduce its effectiveness. Typical side effects include nausea, vomiting, diarrhea, and indigestion. Severe or persistent side effects necessitate immediate medical attention. Seek emergency care for allergic reactions (e.g., rash, itching, swelling, breathlessness). Inform your physician of all current medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid operating vehicles if drowsiness or dizziness occurs. Sufficient rest, a balanced diet, and ample hydration are recommended for optimal recovery. Your doctor may order tests to monitor the medication's impact.
Primary Ingredients of Gram SPN 500mg/250mg Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Gram SPN 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Gram SPN 500mg/250mg Injection:
This medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.
Common Side effects of Gram SPN 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Gram SPN 500mg/250mg Injection:
Administering this medication will be done by your physician or their associate; self-medication is strictly prohibited.
How Gram SPN 500mg/250mg Injection works:
Ceftriaxone/Sulbactam 500mg/250mg injection (Gram SPN) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Sulbactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, thereby hindering bacterial survival. Sulbactam counters bacterial resistance mechanisms, augmenting Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between alcohol and Gram SPN 500mg/250mg Injection.
PregnancySAFE IF PRESCRIBED
Administration of Gram SPN 500mg/250mg Injection is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harmful consequences for offspring; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Gram SPN 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Gram SPN 500mg/250mg Injection can induce drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding the use of Gram SPN 500mg/250mg Injection in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
The 500mg/250mg Gram SPN injection requires careful administration in patients exhibiting severe hepatic impairment; dosage modification may be necessary. Medical advice is recommended. Dosage alteration for this injection is not advised for individuals with mild or moderate liver dysfunction.
What if you forget to take Gram SPN 500mg/250mg Injection :
Omit a Gram SPN 500mg/250mg Injection dose? Seek your physician's advice.
Facts to Know About Gram SPN 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently